July 14, 2025 · Form 4 insider transaction
Altos Venture AG bought 241,514 shares of Onconetix, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 2 days after the transaction.
1. Pursuant to a Subscription Agreement with the Issuer dated December 15, 2023, the Reporting Person purchased Units of Common Stock and warrants (immediately exercised) on September 24, 2024. Under a "make-whole" provision in the Subscription Agreement, the Issuer agreed to adjust the price for the Units by issuing additional shares of Common Stock to the Reporting Person based on the Issuer VWAP (as defined in the Subscription Agreement) during a specified period following the purchase. At the end of the period, the number of additional shares to be issued was determined to be 241,514, and those shares were issued to the Reporting Person on July 14, 2025 pursuant to the "make-whole" provision.; On September 24, 2024, the Issuer effected a 1-for-40 reverse split of its Common Stock, and on June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock.